Dan M. Berger

478 total citations
13 papers, 395 citations indexed

About

Dan M. Berger is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Dan M. Berger has authored 13 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Organic Chemistry and 4 papers in Oncology. Recurrent topics in Dan M. Berger's work include Melanoma and MAPK Pathways (7 papers), Protein Kinase Regulation and GTPase Signaling (6 papers) and Synthesis and biological activity (4 papers). Dan M. Berger is often cited by papers focused on Melanoma and MAPK Pathways (7 papers), Protein Kinase Regulation and GTPase Signaling (6 papers) and Synthesis and biological activity (4 papers). Dan M. Berger collaborates with scholars based in United States and Canada. Dan M. Berger's co-authors include Dennis Powell, Diane H. Boschelli, Biqi Wu, Ramaswamy Nilakantan, Minu Dutia, Fei Ye, Allan Wissner, Nellie Mamuya, Lee M. Greenberger and M. Brawner Floyd and has published in prestigious journals such as Journal of Medicinal Chemistry, Organic Letters and Tetrahedron Letters.

In The Last Decade

Dan M. Berger

13 papers receiving 379 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dan M. Berger United States	11	248	184	92	50	26	13	395
Scott A. Long United States	9	189 0.8×	212 1.2×	56 0.6×	38 0.8×	25 1.0×	13	429
Manolis A. Fousteris Greece	16	341 1.4×	273 1.5×	97 1.1×	39 0.8×	21 0.8×	40	590
Yoshiaki Washio United Kingdom	8	215 0.9×	192 1.0×	50 0.5×	51 1.0×	17 0.7×	11	373
Erli Zhang United States	9	179 0.7×	183 1.0×	76 0.8×	67 1.3×	20 0.8×	11	371
M. Sabat United States	16	354 1.4×	249 1.4×	86 0.9×	63 1.3×	21 0.8×	32	621
Alan Swinamer United States	9	284 1.1×	374 2.0×	102 1.1×	105 2.1×	59 2.3×	9	590
Anna I. Koutsourea Greece	13	226 0.9×	198 1.1×	66 0.7×	33 0.7×	12 0.5×	22	377
Malini Ravi United States	10	231 0.9×	178 1.0×	74 0.8×	77 1.5×	19 0.7×	10	416
Dmitry Borkin United States	15	248 1.0×	250 1.4×	56 0.6×	32 0.6×	7 0.3×	22	538
Hanan M. Refaat Egypt	14	590 2.4×	173 0.9×	69 0.8×	61 1.2×	30 1.2×	22	704

Countries citing papers authored by Dan M. Berger

Since Specialization

Citations

This map shows the geographic impact of Dan M. Berger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan M. Berger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan M. Berger more than expected).

Fields of papers citing papers by Dan M. Berger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan M. Berger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan M. Berger. The network helps show where Dan M. Berger may publish in the future.

Co-authorship network of co-authors of Dan M. Berger

This figure shows the co-authorship network connecting the top 25 collaborators of Dan M. Berger. A scholar is included among the top collaborators of Dan M. Berger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan M. Berger. Dan M. Berger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Wang, Xiaolun, Edward J. Salaski, Dan M. Berger, et al.. (2011). Structure-based design of isoindoline-1,3-diones and 2,3-dihydrophthalazine-1,4-diones as novel B-Raf inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(23). 6941–6944. 11 indexed citations

Crombie, Aimee L., Fuk‐Wah Sum, Dennis Powell, et al.. (2010). Synthesis and biological evaluation of tricyclic anilinopyrimidines as IKKβ inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(12). 3821–3825. 14 indexed citations

Wang, Xiaolun, Dan M. Berger, Edward J. Salaski, et al.. (2010). Indazolylpyrazolopyrimidine as Highly Potent B-Raf Inhibitors with in Vivo Activity. Journal of Medicinal Chemistry. 53(21). 7874–7878. 14 indexed citations

Wang, Xiaolun, Dan M. Berger, Edward J. Salaski, et al.. (2009). Discovery of highly potent and selective type I B-Raf kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(23). 6571–6574. 21 indexed citations

Grandi, Martin J. Di, Dan M. Berger, Darrin W. Hopper, et al.. (2009). Novel pyrazolopyrimidines as highly potent B-Raf inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(24). 6957–6961. 27 indexed citations

Berger, Dan M., Minu Dutia, Dennis Powell, et al.. (2009). Non-hinge-binding pyrazolo[1,5-a]pyrimidines as potent B-Raf kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(23). 6519–6523. 32 indexed citations

Wang, Xiaolun, Edward J. Salaski, Dan M. Berger, & Dennis Powell. (2009). Dramatic Effect of Solvent Hydrogen Bond Basicity on the Regiochemistry of S_NAr Reactions of Electron-Deficient Polyfluoroarenes. Organic Letters. 11(24). 5662–5664. 22 indexed citations

Berger, Dan M., Minu Dutia, Dennis Powell, et al.. (2008). 4-Anilino-7-alkenylquinoline-3-carbonitriles as potent MEK1 kinase inhibitors. Bioorganic & Medicinal Chemistry. 16(20). 9202–9211. 16 indexed citations

Mayer, Scott C., Dan M. Berger, Diane H. Boschelli, et al.. (2008). Lead identification to generate 3-cyanoquinoline inhibitors of insulin-like growth factor receptor (IGF-1R) for potential use in cancer treatment. Bioorganic & Medicinal Chemistry Letters. 19(1). 62–66. 34 indexed citations

10.

Olszewski, John D., et al.. (2007). Carbon‐14 labelling of 3‐cyanoquinolines. Journal of Labelled Compounds and Radiopharmaceuticals. 50(5-6). 578–579. 1 indexed citations

11.

Hopper, Darrin W., Minu Dutia, Dan M. Berger, & Dennis Powell. (2007). Observation of differential reactivity of cyclic amines in SN2 and SNAr displacement reactions in the course of synthesizing C-6, C-7 substituted quinolinecarbonitrile MEK1 kinase inhibitors. Tetrahedron Letters. 49(1). 137–140. 7 indexed citations

12.

Berger, Dan M., Minu Dutia, Gary H. Birnberg, et al.. (2005). 4-Anilino-7,8-dialkoxybenzo[g]quinoline-3-carbonitriles as Potent Src Kinase Inhibitors. Journal of Medicinal Chemistry. 48(19). 5909–5920. 13 indexed citations

13.

Wissner, Allan, Dan M. Berger, Diane H. Boschelli, et al.. (2000). 4-Anilino-6,7-dialkoxyquinoline-3-carbonitrile Inhibitors of Epidermal Growth Factor Receptor Kinase and Their Bioisosteric Relationship to the 4-Anilino-6,7-dialkoxyquinazoline Inhibitors. Journal of Medicinal Chemistry. 43(17). 3244–3256. 183 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact